Steve R Ommen, Carolyn Y Ho, Irfan M Asif, Seshadri Balaji, Michael A Burke, Sharlene M Day, Joseph A Dearani, Kelly C Epps, Lauren Evanovich, Victor A Ferrari, José A Joglar, Sadiya S Khan, Jeffrey J Kim, Michelle M Kittleson, Chayakrit Krittanawong, Matthew W Martinez, Seema Mital, Srihari S Naidu, Sara Saberi, Christopher Semsarian, Sabrina Times, Cynthia Burstein Waldman
AIM: The "2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy" provides recommendations to guide clinicians in the management of patients with hypertrophic cardiomyopathy. METHODS: A comprehensive literature search was conducted from September 14, 2022, to November 22, 2022, encompassing studies, reviews, and other evidence on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline...
May 8, 2024: Circulation